can tirzepatide cause kidney stones Renal effects of GLP-1 receptor agonists and in individuals with type 2 diabetes: seeds of a promising future | Endocrine Mounjaro with One Kidney: Safety

More patients treated with SAXENDA, compared with placebo, had changes from baseline at two consecutive visits of more than 10 bpm (34% versus 19%, respectively) and 20 bpm (5% versus 2%, respectively)

If frequent urination persists or worsens, a healthcare provider can evaluate whether it is a side effect of the medication or a sign of something else

In addition, there are potential applications in the treatment of some diseases, such as in cancer cachexia patients, which may improve weight loss and loss of appetite, and enhance the quality of life of patients

doi: 10.1016/j.bcp.2018.04.010 218 ChadhaSBehlTKumarAKhullarGAroraS